From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster ...

An immunotherapy treatment has been found to ‘change the world’ for head and neck cancer patients by giving them an extra two ...

Abpro Holdings (ABP) and Celltrion unveiled preclinical data for ABP-102/CT-P72 in an oral presentation at the American Association for Cancer ...

Former intel chief says China likely has over 5,000 spies in Taiwan ...

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 ...

The discovery broadens the known spectrum of this rare disorder, emphasizing the critical role of collaboration with patient ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

“Maintaining oral microbial homeostasis is essential,” says dentist Dr Zahraa Maiter. “When the oral microbiome is balanced, ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...